Home
Concordia UK

Concordia UK Market Share Analysis for August 2026

advanz pharma is a global pharmaceutical company determined to deliver sustainable value across our extensive portfolio of specialty generic and legacy-branded, off patent medicines.

Health > Biotechnology and Pharmaceuticals

Domainconcordiarx.com

Year Founded2012

Employees201 - 500

Annual Revenue$500M - $1B

Concordia UK

Concordia UK (including company regionals)

concordiarx.com

See more website traffic and engagement information

Concordia UK Revenue up to August 2026 is 500M - 1B

revenue generated by Concordia UK top domains

Concordia UK top domains revenue over 3 years

Revenue for Concordia UK top domains

concordiarx.com500M - 1B

See more with Sales Intelligence

Total visits to Concordia UK's top domains

Understand Concordia UK market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Concordia UK's top domains

Analyze Concordia UK engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Concordia UK's top domains

See how Concordia UK keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Concordia UK top competitors by domain

Top similar sites in August 2026, ranked by their affinity

avexis.comCompany NameAveXis, Inc.Employees1001 - 5000HQUnited States, Illinois, BannockburnAnnual revenue$15M - $25MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Concordia UK

These are the website technologies, by industry, used by Concordia UK top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

5

See all

News & Signals from Concordia UK

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsConcordiarx hired Robert Sully as General Counsel on Aug 31st '18.Concordia also announced today the appointment of Robert Sully as General Counsel effective August 31, 2018.

NewsJohn Beighton retired from Concordiarx as President of the Company’s International segment on Dec 31st '16.Concordia International Corp. (NASDAQ:CXRX) announced that effective January 1, 2017, John Beighton will retire from his current role as President of the Company’s International segment.

NewsConcordiarx hired Allan Oberman as chief executive on Nov 14th '16.Drug company Concordia International Corp. (CXR.TO 2.29%, CXRX.O) has appointed former Sagent Pharmaceuticals chief executive Allan Oberman as its new chief executive, effective Nov. 14.